An in Vitro–in Vivo Model of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer

Drug Discovery Today: Disease Mechanisms
doi 10.1016/j.ddmec.2012.11.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

In Vitro Antineoplastic Activity in Triple-Negative Breast Cancer Cell Line and in Vivo

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2014English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Epithelial-Mesenchymal Transition in Prostate Cancer: An Overview

Oncotarget
Oncology
2017English

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Long Non-Coding RNA ZEB2-AS1 Promotes the Proliferation, Metastasis and Epithelial Mesenchymal Transition in Triple-Negative Breast Cancer by Epigenetically Activating ZEB2

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy